Wealth Alliance’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$298K Buy
2,529
+387
+18% +$54.1K 0.03% 431
2025
Q4
$351K Buy
2,142
+113
+6% +$17.7K 0.03% 395
2025
Q3
$271K Sell
2,029
-62
-3% -$7.53K 0.03% 447
2025
Q2
$260K Buy
2,091
+255
+14% +$32.5K 0.03% 452
2025
Q1
$234K Buy
+1,836
New +$283K 0.03% 461
2024
Q4
Sell
-1,758
Closed -$262K 533
2024
Q3
$262K Buy
+1,758
New +$252K 0.03% 430
2024
Q2
Sell
-1,338
Closed -$246K 544
2024
Q1
$246K Sell
1,338
-603
-31% -$115K 0.03% 449
2023
Q4
$349K Buy
1,941
+277
+17% +$43.1K 0.05% 340
2023
Q3
$265K Buy
+1,664
New +$272K 0.04% 384

Other funds holding RGEN

Wealth Alliance's RGEN Position: Q1 2026 in Review

Wealth Alliance increased its Repligen (RGEN) stake by 18% in Q1 2026, buying an estimated $54.1K and bringing the position to 2,529 shares worth $298K. The position accounts for 0.03% of the portfolio, ranked #431.

Wealth Alliance first reported a position in RGEN in Q3 2023 and has held it in 9 quarters since. The position peaked at $351K in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Wealth Alliance held 2,529 shares of Repligen worth $298K as of Q1 2026.
  • Wealth Alliance bought 387 Repligen shares in Q1 2026, an estimated $54.1K.
  • Repligen made up 0.03% of Wealth Alliance's portfolio in Q1 2026, its #431 holding.
  • Wealth Alliance first reported a position in Repligen in Q3 2023 and has held it in 9 quarters since.
  • Wealth Alliance's Repligen position peaked at $351K in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Wealth Alliance's 13F filing for Q1 2026, filed 14 May 2026.